首页> 外文期刊>Journal of vascular surgery >The effect of false lumen procedures during thoracic endovascular aortic repair in patients with chronic DeBakey type IIIB dissections
【24h】

The effect of false lumen procedures during thoracic endovascular aortic repair in patients with chronic DeBakey type IIIB dissections

机译:胸腔内血管主动脉患者慢性粘性型IIIB型解剖患者胸腔内血管系瘤期间的影响

获取原文
获取原文并翻译 | 示例
           

摘要

ObjectiveAlthough thoracic endovascular aortic repair (TEVAR) is commonly used for chronic DeBakey type IIIB (CDIIIB) dissections, aortic remodeling outcomes after the procedure have been unsatisfactory. Persistent retrograde flow to the false lumen (FL) through re-entry tears commonly causes treatment failure. The aim of this study was to clarify the safety and effect of the FL procedure (FLP) for aortic remodeling in patients with CDIIIB dissections. MethodsFrom 2012 to 2016, there were 73 patients who underwent TEVAR for CDIIIB dissections. The surgery, accompanied by the FLP, was performed in 41 patients (group A, 56%); 32 patients (group B, 44%) underwent TEVAR alone. The FLP was defined as blocking the retrograde FL flow with commercial materials. Outcomes included whole thoracic aorta FL thrombosis and diameter change in the true lumen and FL. Diameters were measured at three levels (left subclavian artery, pulmonary artery bifurcation, and celiac axis). ResultsNo in-hospital mortality was observed. There was one case each of paraplegia and stroke postoperatively. The whole thoracic aorta FL thrombosis rate was significantly higher in group A (83% vs 56%;P?= .002). Significant aortic remodeling (true lumen expansion and FL regression) was observed in both groups. In multivariable Cox regression analysis, the FLP and the number of re-entries were independent predictors for thoracic FL thrombosis (hazard ratio, 2.339 [P?= .009] and 0.709 [P?< .001], respectively). ConclusionsFull-coverage TEVAR with the FLP seems to be a safe endovascular treatment and promotes thoracic FL thrombosis for patients with CDIIIB dissections.
机译:Objectivough胸腔内血管内主动脉修复(TEVAR)通常用于慢性粘性型IIIB(CDIIIB)解剖,程序后的主动脉改造结果不令人满意。通过再进入泪液,持续逆行流到假腔(FL)通常会导致治疗失败。本研究的目的是阐明FL程序(FLP)对CDIIIB解剖患者主动重塑的安全性和效果。方法从2012年到2016年,有73名患者接受了CDIIIB解剖的TEVAR。伴有FLP的手术在41名患者中进行(A组,56%); 32例患者(B组,44%)单独接受Tevar。 FLP被定义为阻止与商业材料的逆行流程。结果包括整个胸部主动脉血栓形成和直径变化真正的腔和FL。直径在三个层次(左亚克拉夫动脉,肺动脉分叉和乳糜泻)测量。观察到康斯托纳院内死亡率。截瘫患者每种情况和术后一例。全部胸主动脉血栓形成率在A组(83%vs 56%; p?= .002)中显着高。在这两组中观察到显着的主动脉重塑(真正的腔膨胀和流失)。在多变量的Cox回归分析中,FLP和重新进入的数量是胸部血栓形成的独立预测因子(危险比,2.339 [p?= .009]和0.709 [p?<.001])。结论Compluids Tevar与FLP似乎是安全的血管内治疗,促进CDIIIB解剖患者的胸血栓形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号